Barrington Research Reiterates “Outperform” Rating for Henry Schein (NASDAQ:HSIC)

Barrington Research reaffirmed their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a research report report published on Wednesday,Benzinga reports. They currently have a $90.00 price target on the stock. Barrington Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.04 EPS, Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

Other analysts also recently issued research reports about the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Performance

Shares of HSIC stock opened at $72.17 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The stock has a 50 day moving average price of $74.35 and a two-hundred day moving average price of $72.42. The company has a market capitalization of $9.00 billion, a P/E ratio of 29.70, a PEG ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the firm posted $0.66 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. Analysts expect that Henry Schein will post 4.74 earnings per share for the current year.

Institutional Investors Weigh In On Henry Schein

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. Investment Management Corp VA ADV purchased a new stake in Henry Schein in the fourth quarter worth $32,000. Venturi Wealth Management LLC grew its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC grew its stake in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.